文献速递中医内科中药与中成药合理使用

中药联合西药对高血压患者血管内皮功能影响的系统评价与Meta分析

The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Front Pharmacol · 2020-06-16

该系统评价纳入30项随机对照试验共3235例高血压患者,评估中药联合西药对比单用西药对血管内皮功能的影响。Meta分析显示联合治疗在降低血压、升高一氧化氮、降低内皮素-1及改善血流介导舒张方面更优,但主要心脑血管事件无显著差异,证据质量低。

要点

  • 中药联合西药较单用西药更有效降低血压(RR=1.21,95%CI 1.16-1.26)。
  • 联合治疗可升高一氧化氮(95%CI 1.24-2.08,P<0.00001)并降低内皮素-1(95%CI -1.71至-1.14,P<0.00001)。
  • 联合治疗改善血流介导舒张(95%CI 0.98-1.31,P<0.00001),但主要心脑血管事件无显著差异。

核心结论

  • 中药联合常规西药可能有效降低高血压患者血压并改善血管内皮功能。
  • 联合治疗与单用西药在主要心脑血管事件上无显著差异。
  • 现有证据质量低,需更多大样本、严格随机的研究进一步证实。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Cochrane Central Register of Controlled Trials、中国生物医学文献数据库、中国知识资源总库、万方数据、中国科技期刊数据库。
  • 纳入30项随机对照试验,共3235例高血压患者。
  • 使用RevMan 5.3.0进行数据分析,GRADEpro对证据质量进行分级。

主要发现

  • 联合治疗降低血压的风险比(RR)为1.21(95%CI 1.16至1.26)。
  • 联合治疗升高一氧化氮的95%CI为1.24至2.08(P<0.00001)。
  • 联合治疗降低内皮素-1的95%CI为-1.71至-1.14(P<0.00001)。
  • 联合治疗改善血流介导舒张的95%CI为0.98至1.31(P<0.00001)。
  • 联合治疗与单用西药在主要心脑血管事件上无显著差异。

关键数值与推荐

  • 联合治疗降低血压的RR为1.21(95%CI 1.16至1.26)。
  • 联合治疗升高一氧化氮的95%CI为1.24至2.08(P<0.00001)。
  • 联合治疗降低内皮素-1的95%CI为-1.71至-1.14(P<0.00001)。
  • 联合治疗改善血流介导舒张的95%CI为0.98至1.31(P<0.00001)。
  • GRADEpro评级显示现有数据证据质量低。

临床怎么用

  • 在常规西药基础上联用中药可能有助于进一步降低血压并改善血管内皮功能。
  • 联合治疗对主要心脑血管事件的影响尚不明确,需结合患者个体情况决策。
  • 应关注证据质量低的局限性,谨慎解读联合治疗的获益。

局限性

  • 纳入研究存在较高的选择偏倚和实施偏倚。
  • GRADEpro评级显示现有数据证据质量低。
  • 需要更多大样本、严格随机、检测和报告过程清晰的研究进一步证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Vascular endothelium plays a fundamental role in regulating endothelial dysfunction, resulting in structural changes that may lead to adverse outcomes of hypertension. The aim of this study was to systematically evaluate the effect of a combination of Chinese herbal medicine (CHM) and Western medicine on vascular endothelial function in patients with hypertension. METHODS: We systematically searched the literature for studies published in Chinese and English in PubMed, Embase, Cochrane Central Register of Controlled Trials, Chinese Biomedical Literature Database, China Knowledge Resource Integrated Database, Wanfang Data, and China Science and Technology Journal Database. Databases were searched using terms concerning or describing CHM, hypertension, vascular endothelium, and randomized controlled trials. RevMan 5.3.0 was used for data analysis. If the included studies were sufficiently homogeneous, quantitative synthesis was performed; if studies with different sample sizes and blind methods were used, subgroup analyses were performed. GRADEpro was selected to grade the current evidence to reduce bias in our findings. RESULTS: In this review, 30 studies with 3,235 patients were enrolled. A relatively high selection and a performance bias were noted by risk of bias assessments. Meta-analysis showed that the combination of CHM and conventional Western medicine was more efficient than conventional Western medicine alone in lowering blood pressure (risk ratio, 1.21; 95% CI, 1.16 to 1.26) and increasing nitric oxide (95% CI, 1.24 to 2.08; P < 0.00001), endothelin-1 (95% CI, -1.71 to -1.14; P < 0.00001), and flow-mediated dilation (95% CI, 0.98 to 1.31; P <0.00001). No significant difference was observed between the combination of CHM and conventional Western medicine and conventional Western medicine alone for major cardiovascular and cerebrovascular events. CHM qualified for the treatment of hypertension. The GRADEpro presented with low quality of evidence for the available data. CONCLUSION: CHM combined with conventional Western medicine may be effective in lowering blood pressure and improving vascular endothelial function in patients with hypertension. To further confirm this, more well-designed studies with large sample sizes, strict randomization, and clear descriptions about detection and reporting processes are warranted.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Ren W, Wang M, Liao J, et al. The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol. 2020. PMID: 32612527. doi:10.3389/fphar.2020.00823

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。